Related Experiment Video
Updated: Dec 25, 2025

Flow Cytometry-based Assay for the Monitoring of NK Cell Functions
Published on: October 30, 2016
HKDC1 C-terminal based peptides inhibit extranodal natural killer/T-cell lymphoma by modulation of mitochondrial
Qi Chen1, Jia Feng1, Jinhu Wu2
1Department of Hematology, Peking University Shenzhen Hospital, Shenzhen, 518036, PR China.
Abstract:
Extranodal nasal-type natural killer/T-cell lymphoma (ENKTL) is an Epstein-Barr virus (EBV) associated lymphoma that progresses rapidly and relapses frequently. Advanced ENKTL is multidrug chemoresistant and has a poor prognosis. In this study, we aim to develop a novel hexokinase domain component 1 (HKDC1)-based antitumor target for ENKTL that is involved with the antimetabolic signaling pathway, EBV replication, and P-glycoprotein (P-gp) expression. We showed that HKDC1 is highly upregulated in ENKTL cells and HKDC1 knockdown significantly suppresses ENKTL tumor growth. In addition, HKDC1 is highly identical with four other hexokinase isoforms, with the only difference being in the last eight amino acids (aa) at the C-terminal. Further investigation showed that peptide delivery of the last eight aa of HKDC1 at the C-terminal (HKC8) with D-configuration using transferrin (Tf) receptor internalization sequence (Tf-D-HKC8) inhibits HKDC1 association with vascular endothelial growth factor 1 (VDAC1), resulting in mitochondrial dysfunction and reactive oxygen species (ROS) overgeneration and subsequently suppressing EBV replication and P-gp expression, making it very effective in killing EBV-positive ENKTL cells. Further in vivo experiments showed that local injection of Tf-D-HKC8 peptide significantly suppresses ENKTL tumor growth and EBV replication in ENKTL xenograft mouse models. We conclude that HKDC1 C-terminal-based peptides inhibit ENKTL by modulation of mitochondrial function and EBV suppression.
Insights
A novel peptide targeting hexokinase domain component 1 (HKDC1) effectively inhibits extranodal nasal-type natural killer/T-cell lymphoma (ENKTL) growth. This peptide suppresses Epstein-Barr virus (EBV) replication and P-glycoprotein expression by disrupting mitochondrial function.
Area of Science:
- Oncology
- Virology
- Biochemistry
Background:
- Extranodal nasal-type natural killer/T-cell lymphoma (ENKTL) is an aggressive, relapsing lymphoma associated with Epstein-Barr virus (EBV).
- Advanced ENKTL exhibits chemoresistance and a poor prognosis, necessitating novel therapeutic strategies.
- Hexokinase domain component 1 (HKDC1) is implicated in antimetabolic pathways, EBV replication, and P-glycoprotein (P-gp) expression in ENKTL.
Purpose of the Study:
- To develop a novel HKDC1-based antitumor target for ENKTL.
- To investigate the role of HKDC1 in ENKTL pathogenesis, including its involvement in EBV replication and P-gp expression.
- To evaluate the therapeutic potential of a targeted peptide derived from HKDC1.
Main Methods:
- HKDC1 expression levels were analyzed in ENKTL cells.
- HKDC1 knockdown was performed to assess its impact on tumor growth.
- A peptide (Tf-D-HKC8) targeting the C-terminal of HKDC1 was designed and synthesized.
- The peptide's mechanism of action, including effects on mitochondrial function, EBV replication, and P-gp expression, was investigated.
- In vivo efficacy was evaluated using ENKTL xenograft mouse models.
Main Results:
- HKDC1 was significantly upregulated in ENKTL cells, and its knockdown suppressed tumor growth.
- The Tf-D-HKC8 peptide inhibited the association of HKDC1 with VDAC1, leading to mitochondrial dysfunction and reactive oxygen species (ROS) overgeneration.
- The peptide effectively suppressed EBV replication and P-gp expression in ENKTL cells.
- Local injection of Tf-D-HKC8 peptide significantly inhibited tumor growth and EBV replication in vivo.
Conclusions:
- HKDC1 is a critical target for ENKTL therapy.
- The C-terminal peptide Tf-D-HKC8 demonstrates potent antitumor activity against ENKTL by modulating mitochondrial function and suppressing EBV.
- HKDC1-based peptides represent a promising therapeutic approach for EBV-positive ENKTL.
More Related Videos
Related Concept Videos
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Cells of the Innate Immune Response
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
Inhibition of Cdk Activity

